How to Microdose LSD: Protocols, Doses, and What the Research Actually Shows
Legal framing first: LSD is a Schedule I controlled substance in the United States and illegal in most countries. This article is written for harm reduction purposes and for readers in jurisdictions where psychedelics are decriminalized or where research is authorized. It does not encourage illegal activity.
With that established: LSD microdosing is one of the most studied sub-perceptual psychedelic practices, and the honest evidence picture is more nuanced than the Silicon Valley narrative suggests.
Why Blinded Studies Show More Modest Effects
The self-report microdosing literature is enthusiastic. Most large-scale surveys find that the majority of participants report improved mood, focus, and creativity. The problem is that most people know whether they are microdosing, which introduces expectation effects.
When blinded — when participants don't know if they received an active dose or placebo — the benefits are smaller and more variable. Several well-designed studies have found that participants who believe they are microdosing (regardless of whether they actually are) report benefits, and those who receive an active dose without knowing show more modest improvements than self-reporters.
This does not mean microdosing does nothing. It means that expectation and attention to positive effects contribute substantially to the reported experience. Knowing this matters for self-assessment: your subjective sense of improvement on a dose day may not be entirely attributable to the compound.
If you are microdosing, you are also receiving a high-quality placebo. That is not an insult — it means your mindset and intention are part of the mechanism. But it also means self-report is not a reliable measure of pharmacological effect.
Protocols, Compared
| Protocol | Schedule | Approach | Evidence Base | Common Reported Outcome |
|---|---|---|---|---|
| Fadiman Protocol | 1 day on, 2 days off | Fixed dose (5–10 mcg), consistent timing, journal tracking | Best documented self-report base; subject of several research surveys | Improved focus and mood on dose days; minimal tolerance buildup |
| Stamets Protocol | 4 days on, 3 days off | Combines LSD or psilocybin with lion's mane and niacin | Limited — the combination is specific to Stamets; lion's mane component is separately studied | Neurogenesis focus; more complex to implement and assess |
| Every Other Day | Alternating days | Simpler schedule; slightly higher tolerance risk | Minimal controlled evidence | Convenience; potentially higher tolerance accumulation |
| Custom / Intuitive | As-needed or varied | No fixed schedule; dose when conditions seem right | Minimal — difficult to study | Variable; confirmation bias risk is highest here |
Dose Guidance
A true microdose is sub-perceptual — you should not notice obvious changes in your perception, mood, or cognition. If you notice you are in an altered state, the dose is too high.
The standard starting point is 5–10 micrograms. This is typically achieved through dilution — making a solution in distilled water and volumetrically dosing, since tabs vary significantly in actual content. Without testing and volumetric dosing, the "same tab, half a tab" approach has unpredictable precision.
LSD is extremely dose-sensitive. The difference between 5 mcg and 15 mcg is meaningful in terms of perceptual effects. Imprecise dosing is the most common reason people report unexpected effects from what they thought was a microdose.
Tolerance
LSD produces cross-tolerance with other serotonergic psychedelics rapidly. Daily dosing leads to receptor downregulation that reduces effects significantly within a few days. This is why rest days are built into every established protocol — not for safety, but for effectiveness.
A common error is to increase dose when tolerance reduces the felt effect, rather than taking a rest period. Escalating dose to chase the original effect typically pushes beyond the sub-perceptual range and introduces the kind of perceptual shifts that interfere with ordinary function.
Tracking Your Results Honestly
Keeping a structured log is more valuable than subjective impression. The most common tracking approach: rate mood, focus, energy, and social ease on a 1–10 scale every morning, noting whether it's a dose day or rest day, and reviewing weekly.
This structure separates signal from noise more reliably than asking yourself "does this seem to be helping?" On dose days, you are predisposed to notice positive effects. On rest days, you may be predisposed to notice their absence. Numerical tracking is an imperfect correction for this bias, but it's better than nothing.
Technospermia Lens (Tier 3)
LSD produces measurable neurological effects at doses in the single-digit microgram range — quantities so small they are invisible to the naked eye. This is an extraordinary level of biological precision. Molecules at microgram concentrations binding to serotonin receptors and producing detectable changes in default mode network activity represents a degree of pharmacological specificity that is difficult to account for by ordinary natural processes. The Technospermia framework treats this extreme dose-sensitivity as consistent with designed biological technology — calibrated rather than approximate.
Legal and Medical Disclaimer
LSD is a Schedule I controlled substance in the United States and illegal in most countries. Possession, manufacture, and distribution carry serious legal penalties. This article is provided strictly for harm reduction purposes and for readers in jurisdictions where possession is decriminalized or research is authorized. It does not encourage illegal activity. This article is informational only and does not constitute medical advice. Do not use any illegal substance without understanding the legal risks in your jurisdiction.
Related Reading
- The Technospermia Theory: Why microgram-level biological precision may indicate design
- Psilocybin Microdose Protocols: The mushroom equivalent — better evidence base, different phenomenology
- What Does Microdosing Feel Like?: The experiential account of sub-perceptual dosing
Share this transmission